Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

693 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of effectiveness and safety of three different antithrombotic regimens (bivalirudin, eptifibatide, and heparin) in preventing myocardial ischemia during percutaneous coronary intervention.
Wolfram R, Leborgne L, Cheneau E, Pinnow EE, Canos DA, Hellinga D, Satler LF, Pichard AD, Kent KM, Waksman R. Wolfram R, et al. Among authors: pichard ad. Am J Cardiol. 2003 Nov 1;92(9):1080-3. doi: 10.1016/j.amjcard.2003.06.004. Am J Cardiol. 2003. PMID: 14583359
Addition of heparin to contrast media is associated with increased bleeding and peripheral vascular complications during percutaneous coronary intervention with bivalirudin and drug-eluting stents.
Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Gebreeyesus A, Aggrey G, Pichard AD, Satler LF, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: pichard ad. Cardiovasc Radiat Med. 2004 Apr-Jun;5(2):64-70. doi: 10.1016/j.carrad.2004.06.003. Cardiovasc Radiat Med. 2004. PMID: 15464942
Bivalirudin versus heparin as an antithrombotic agent in patients who undergo percutaneous saphenous vein graft intervention with a distal protection device.
Rha SW, Kuchulakanti PK, Pakala R, Cheneau E, Pinnow E, Torguson R, Pichard AD, Satler LF, Suddath WO, Kent KM, Lindsay J, Waksman R. Rha SW, et al. Among authors: pichard ad. Am J Cardiol. 2005 Jul 1;96(1):67-70. doi: 10.1016/j.amjcard.2005.02.047. Am J Cardiol. 2005. PMID: 15979436 Clinical Trial.
Brachytherapy and bivalirudin evaluation study.
Kuchulakanti P, Wolfram R, Torguson R, Rha SW, Cheneau E, Pinnow EE, Canos D, Satler LF, Pichard AD, Kent KM, Waksman R. Kuchulakanti P, et al. Among authors: pichard ad. Am Heart J. 2005 Oct;150(4):832-7. doi: 10.1016/j.ahj.2004.11.013. Am Heart J. 2005. PMID: 16209990
MRI evaluation of a coronary artery perforation.
Clavijo LC, Yar O, Kuchulakanti P, Chu WW, Suddath WO, Satler LF, Kent KM, Waksman R, Pichard AD. Clavijo LC, et al. Among authors: pichard ad. Cardiovasc Revasc Med. 2005 Jan-Mar;6(1):44-5. doi: 10.1016/j.carrev.2005.06.001. Cardiovasc Revasc Med. 2005. PMID: 16263356 No abstract available.
693 results